Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term renal cell. Found 14 abstracts

Lee Z, Jegede OA, Haas NB, Pins MR, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MA, Flaherty KT, Dutcher JP, DiPaola RS, Uzzo RG. Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial. J Urol. 2020 Apr;203(4):684-9.
Haifler M, Ristau BT, Higgins AM, Smaldone MC, Kutikov A, Zisman A, Uzzo RG. External Validation of Contact Surface Area as a Predictor of Postoperative Renal Function in Patients Undergoing Partial Nephrectomy. J Urol. 2018 Mar;199(3):649-54.
Haifler M, Ristau BT, Higgins AM, Smaldone MC, Kutikov A, Zisman A, Uzzo RG. External Validation of Contact Surface Area as a Predictor of Postoperative Renal Function in Patients Undergoing Partial Nephrectomy. J Urol. 2017 Sep 20;.
Ito T, Derweesh IH, Ginzburg S, Abbosh PH, Raheem OA, Mirheydar H, Hamilton Z, Chen DY, Smaldone MC, Greenberg RE, Viterbo R, Kutikov A, Uzzo RG. Perioperative Outcomes Following Partial Nephrectomy Performed on Patients Remaining on Antiplatelet Therapy. J Urol. 2017 Jan;197(1):31-6.
Ito T, Derweesh IH, Ginzburg S, Abbosh PH, Raheem OA, Mirheydar H, Hamilton Z, Chen DY, Smaldone MC, Greenberg RE, Viterbo R, Kutikov A, Uzzo RG. Perioperative Outcomes Following Partial Nephrectomy Performed on Patients Remaining on Antiplatelet Therapy. J Urol. 2017 Jan;197(1):31-6.
Minervini A, Campi R, Kutikov A, Montagnani I, Sessa F, Serni S, Raspollini MR, Carini M. Histopathological Validation of the Surface-Intermediate-Base Margin Score for Standardized Reporting of Resection Technique during Nephron Sparing Surgery. J Urol. 2015 Oct;194(4):916-22.
Ginzburg S, Uzzo R, Al-Saleem T, Dulaimi E, Walton J, Corcoran A, Plimack E, Mehrazin R, Tomaszewski J, Viterbo R, Chen DY, Greenberg R, Smaldone M, Kutikov A. Coexisting Hybrid Malignancy in a Solitary Sporadic Solid Benign Renal Mass: Implications for Treating Patients Following Renal Biopsy. Journal of Urology. 2014 Feb;191(2):296-300.   PMCID: PMC4083459
Mehrazin R, Smaldone MC, Kutikov A, Li T, Tomaszewski JJ, Canter DJ, Viterbo R, Greenberg RE, Chen DY, Uzzo RG. Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance. J Urol. 2014 Sep;192(3):659-64.   PMCID: 4419692
Hoffman AM, Cairns P. Epigenetics of kidney cancer and bladder cancer. Epigenomics. 2011 Feb;3(1):19-34.   PMCID: NIHMS362391
Plimack ER, Hudes GR. Selecting Targeted Therapies for Patients With Renal Cell Carcinoma. Journal of the National Comprehensive Cancer Network. 2011 Sep;9(9):997-1007.   PMCID: not NIH funded
Kunkle DA, Crispen PL, Chen DY, Greenberg RE, Uzzo RG. Enhancing renal masses with zero net growth during active surveillance. Journal of Urology. 2007 Mar;177(3):849-53.
Kunkle DA, Crispen PL, Li TY, Uzzo RG. Tumor size predicts synchronous metastatic renal cell carcinoma: Implications for surveillance of small renal masses. Journal of Urology. 2007 May;177(5):1692-6.
Motzer RJ, Michaelson MD, Rosenberg J, Bukowski RM, Curti BD, George DJ, Hudes GR, Redman BG, Margolin KA, Wilding G. Sunitinib efficacy against advanced renal cell carcinoma. Journal of Urology. 2007 Nov;178(5):1883-7.
Matin SF, Ahrar K, Cadeddu JA, Gervais DA, McGovern FJ, Zagoria RA, Uzzo RG, Haaga J, Resnick MI, Kaouk J, Gill IS. Residual and recurrent disease following renal energy ablative therapy: A multi-institutional study. JOURNAL OF UROLOGY. 2006 Nov;176(5):1973-7.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term renal cell

renal cell carcinoma kidney pathology nephrectomy Female Male Middle Aged Kidney Neoplasms diagnostic imaging Aged kidney neoplasms Nephrectomy aspirin Neoplasm Staging models sunitinib Adult Renal Cell Carcinoma prognosis epidemiology hemorrhage therapy cell carcinoma CANCER surgery clopidogrel tumors theoretical mathematical concepts methylation Clopidogrel Follow-Up Studies Time Factors STAGE Randomized Controlled Trials as Topic dna methylation cryotherapy parenchymal volume etiology genetics risks Prospective Studies surveillance accuracy CELL CARCINOMA Treatment Outcome Coronary Thrombosis Postoperative Hemorrhage percutaneous biopsy Tumor Burden Perioperative Period catheter ablation complications Urology & Nephrology methods medullary survival masses needle core biopsy local Phase III Clinical Trials as Topic oxyphilic cpg-island methylation neoplasm metastasis statistics & numerical data adverse effects KIDNEY Retrospective Studies radical nephrectomy competing clear-cell SU11248 Prognosis t1b Blood Transfusion randomized-trial tumor-suppressor gene clear cell renal cell carcinoma Antineoplastic Agents NEPHRECTOMY NATURAL-HISTORY gene outcomes non-clear cell renal cell carcinoma evidence-based medicine tumor suppressor gene bevacizumab colorectal-cancer disease progression ENDOTHELIAL GROWTH-FACTOR guided radiofrequency ablation e-cadherin Aspirin renal-cell carcinoma Sorafenib cryoablation aberrant promoter phase-iii trial parameter experience collecting duct carcinoma Watchful Waiting Adjuvant Chemotherapy classification Surgical Blood Loss watchful waiting growth-factor-beta Sunitinib INTERFERON-ALPHA DIAMETER Age Factors Risk Factors SURVIVAL CLASSIFICATION 80 and over Aged validation studies MANAGEMENT LESS RANDOMIZED-TRIAL INTERLEUKIN-2 Patient Readmission Local Neoplasm Recurrence TUMOR SIZE Carcinoma NEPHRON-SPARING SURGERY radio-frequency ablation mortality promoter hypermethylation 2010 dermott df-v28 INHIBITOR Kinetics clinical-trials FEATURES Disease-Free Survival LESIONS nephron-sparing surgery active chemotherapy neoplasm staging score THERAPY Kidney oncocytoma therapeutic use methylome Multicenter Studies as Topic observation adenoma natural history germline mutations
Last updated on Wednesday, July 08, 2020